Cancer that develops in the prostate (a gland that forms part of the male reproductive system).
Whole genome sequencing data from 500,000 British volunteers has been released globally by UK Biobank, for scientific research...
A DNA repair pathway has been revealed to be dependent on an enzyme linked with hereditary breast cancer, ovarian cancer, and prostate cancer...
Polygenic scores can enhance the accuracy of prostate cancer screening tests to detect aggressive cancers and help avoid some unnecessary biopsies...
Polygenic risk scores could help GPs to decide which patients to refer for prostate biopsies...
A mitochondrial gene has been identified as a potential therapeutic target for prostate cancers that have spread to other parts of the body and evade current treatment strategies...
BRCA gene mutations have been linked to cancers, including prostate and breast cancer in men, in the largest study to date...
Direct-to-consumer genomic testing is a thriving market – for example by June 2020, 23andMe had sold over a quarter of a million testing kits in the UK...
Black men present genetic variations that make them more vulnerable than white men to developing prostate cancer research revealed...
A drug already used to treat breast and ovarian cancer can also significantly delay the progression of prostate cancer...
The largest-ever study of cancer genomes, the Pan-Cancer Project, has published a collection of 23 papers as the result of a ten-year collaboration...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
